News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Corindus Vascular Robotics Reports Third Quarter 2016 Results



11/9/2016 1:13:00 PM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
''

WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, today reported financial results for the three and nine month periods ended September 30, 2016.

“While our revenue for the quarter was limited, I am very pleased with our solid operational progress”

Recent Highlights and Accomplishments

  • Realized revenue of $688,000 in the third quarter of 2016, primarily from CorPath® System revenue as well as cassette, accessory and service revenue
  • Installed one new CorPath System in the third quarter of 2016 increasing the total installed base to 41 CorPath Systems
  • Received 510(k) clearance from the FDA for CorPath GRX, the second generation CorPath System
  • Established collaboration with ACIST Medical Systems to integrate advanced technologies for PCI
    • Robotic therapy incorporating Fractional Flow Reserve (FFR) and automated contrast delivery may provide workflow solutions to potentially improve clinical outcomes and enhance patient care
  • Approximately 100 attendees at the Transcatheter Cardiovascular Therapeutics (TCT) 2016 annual meeting participated in the breakfast symposium, “Robotic Therapy: Current Applications and Future Vision” chaired by Dr. Martin Leon of New York Presbyterian Hospital
  • Rounded out new leadership team with two key additions
    • Appointed Jeff Lemaster as Chief Commercial Officer
    • Appointed Suzette Jaskie as Vice President Global Medical Affairs

“While our revenue for the quarter was limited, I am very pleased with our solid operational progress,” said Mark Toland, President and Chief Executive Officer of Corindus. “We have made important investments in new talent, and now have a solid leadership team in place as we enter the new year.”


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES